Phase II Trial of Sorafenib in Advanced Thyroid Cancer
GUPTA-ABRAMSON, Vandana, TROXEL, Andrea B, BROSE, Marcia S, NELLORE, Anoma, PUTTASWAMY, Kanchan, REDLINGER, Maryann, RANSONE, Kathy, MANDEL, Susan J, FLAHERTY, Keith T, LOEVNER, Laurie A, O'DWYER, Peter J
Published in Journal of clinical oncology (10.10.2008)
Published in Journal of clinical oncology (10.10.2008)
Get full text
Journal Article
A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel
Flaherty, Keith T, Schiller, Joan, Schuchter, Lynn M, Liu, Glenn, Tuveson, David A, Redlinger, Maryann, Lathia, Chetan, Xia, Chenghua, Petrenciuc, Oana, Hingorani, Sunil R, Jacobetz, Michael A, Van Belle, Patricia A, Elder, David, Brose, Marcia S, Weber, Barbara L, Albertini, Mark R, O'Dwyer, Peter J
Published in Clinical cancer research (01.08.2008)
Published in Clinical cancer research (01.08.2008)
Get full text
Journal Article
Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma
Haas, Naomi B, Appleman, Leonard J, Stein, Mark, Redlinger, Maryann, Wilks, Melissa, Xu, Xiaowei, Onorati, Angelique, Kalavacharla, Anusha, Kim, Taehyong, Zhen, Chao Jie, Kadri, Sabah, Segal, Jeremy P, Gimotty, Phyllis A, Davis, Lisa E, Amaravadi, Ravi K
Published in Clinical cancer research (01.04.2019)
Published in Clinical cancer research (01.04.2019)
Get full text
Journal Article
Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer
STEVENSON, James P, REDLINGER, Maryann, KLUIJTMANS, Leo A. J, WEIJING SUN, ALGAZY, Kenneth, GIANTONIO, Bruce, HALLER, Daniel G, HARDY, Christine, WHITEHEAD, Alexander S, O'DWYER, Peter J
Published in Journal of clinical oncology (15.10.2001)
Published in Journal of clinical oncology (15.10.2001)
Get full text
Journal Article
Phase I and Pharmacokinetic Trial of the Proapoptotic Sulindac Analog CP-461 in Patients with Advanced Cancer
Sun, Weijing, Stevenson, James P, Gallo, James M, Redlinger, Maryann, Haller, Daniel, Algazy, Kenneth, Giantonio, Bruce, Alila, Hector, O'Dwyer, Peter J
Published in Clinical cancer research (01.10.2002)
Get full text
Published in Clinical cancer research (01.10.2002)
Journal Article
Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma
Rangwala, Reshma, Chang, Yunyoung C, Hu, Janice, Algazy, Kenneth M, Evans, Tracey L, Fecher, Leslie A, Schuchter, Lynn M, Torigian, Drew A, Panosian, Jeffrey T, Troxel, Andrea B, Tan, Kay-See, Heitjan, Daniel F, DeMichele, Angela M, Vaughn, David J, Redlinger, Maryann, Alavi, Abass, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, O'Dwyer, Peter J, Amaravadi, Ravi K
Published in Autophagy (01.08.2014)
Published in Autophagy (01.08.2014)
Get full text
Journal Article
Radiomic profiles via machine learning to predict response, overall survival, and KRAS status in metastatic colorectal tumors treated with FOLFOX/bevacizumab/hydroxychloroquine
Rathore, Saima, O'Hara, Mark H., Karasic, Thomas Benjamin, Redlinger, Maryann, Rosen, Mark Alan, Davatzikos, Christos, O'Dwyer, Peter
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Phase II trial of the autophagy inhibitor hydroxychloroquine with FOLFOX and bevacizumab in front line treatment of metastatic colorectal cancer
O'Hara, Mark H., Karasic, Thomas Benjamin, Vasilevskaya, Irina, Redlinger, Maryann, Loaiza-Bonilla, Arturo, Teitelbaum, Ursina R., Giantonio, Bruce J., Damjanov, Nevena, Reiss, Kim Anna, Rosen, Mark Alan, Heitjan, Daniel F, Troxel, Andrea B., Amaravadi, Ravi K., O'Dwyer, Peter J.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study
Flaherty, Keith T., Lathia, Chetan, Frye, Reginald F., Schuchter, Lynn, Redlinger, Maryann, Rosen, Mark, O’Dwyer, Peter J.
Published in Cancer chemotherapy and pharmacology (01.11.2011)
Published in Cancer chemotherapy and pharmacology (01.11.2011)
Get full text
Journal Article
Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX/bevacizumab in the first-line treatment of advanced colorectal cancer
Loaiza-Bonilla, Arturo, O'Hara, Mark H., Redlinger, Maryann, Damjanov, Nevena, Teitelbaum, Ursina R., Vasilevskaya, Irina, Rosen, Mark Alan, Heitjan, Daniel F, Amaravadi, Ravi K., O'Dwyer, Peter J.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer
Ciunci, Christine A., Perini, Rodolfo F., Avadhani, Anjali N., Kang, Hyunseon C., Sun, Weijing, Redlinger, Maryann, Harlacker, Kathleen, Flaherty, Keith T., Giantonio, Bruce J., Rosen, Mark A., Divgi, Chaitanya R., Song, Hee Kwon, Englander, Sarah, Troxel, Andrea, Schnall, Mitchell, O'Dwyer, Peter J.
Published in Cancer (01.01.2014)
Published in Cancer (01.01.2014)
Get full text
Journal Article
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
Denlinger, Crystal S, Blanchard, Rebecca, Xu, Lu, Bernaards, Coen, Litwin, Samuel, Spittle, Cynthia, Berg, Daniel J, McLaughlin, Susan, Redlinger, Maryann, Dorr, Andrew, Hambleton, Julie, Holden, Scott, Kearns, Anne, Kenkare-Mitra, Sara, Lum, Bert, Meropol, Neal J, O'Dwyer, Peter J
Published in Cancer chemotherapy and pharmacology (01.12.2009)
Published in Cancer chemotherapy and pharmacology (01.12.2009)
Get full text
Journal Article
Abstract 4500: Combined mTOR inhibition and autophagy inhibition: Phase I trial of temsirolimus and hydroxchloroquine in patients with advanced solid tumors
Algazy, Kenneth M., Schuchter, Lynn M., Demichele, Angela M., David, Vaughn J., Torigian, Drew A., Chang, Claire Y., Redlinger, Maryann, Davis, Lisa E., O'Dwyer, Peter J., Amaravadi, Ravi K.
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
DENLINGER, Crystal S, BLANCHARD, Rebecca, HAMBLETON, Julie, HOLDEN, Scott, KEARNS, Anne, KENKARE-MITRA, Sara, LUM, Bert, MEROPOL, Neal J, O'DWYER, Peter J, LU XU, BERNAARDS, Coen, LITWIN, Samuel, SPITTLE, Cynthia, BERG, Daniel J, MCLAUGHLIN, Susan, REDLINGER, Maryann, DORR, Andrew
Published in Cancer chemotherapy and pharmacology (2010)
Get full text
Published in Cancer chemotherapy and pharmacology (2010)
Journal Article
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine
FLAHERTY, Keith T, STEVENSON, James P, REDLINGER, Maryann, ALGAZY, Kenneth M, GIANTONIO, Bruce, O'DWYER, Peter J
Published in Cancer chemotherapy and pharmacology (01.05.2004)
Published in Cancer chemotherapy and pharmacology (01.05.2004)
Get full text
Journal Article
Irinotecan and UFT/leucovorin in patients with advanced cancers
Stevenson, J P, Redlinger, M, Sun, W, Haller, D, O'Dwyer, P J
Published in Oncology (Williston Park, N.Y.) (01.10.2000)
Get more information
Published in Oncology (Williston Park, N.Y.) (01.10.2000)
Journal Article